Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion type Assertion NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_head.
- NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion description "[In the childhood cancer neuroblastoma (NB), the level of expression of the multidrug resistance-associated protein (MRP1) gene is strongly correlated with expression of the MYCN oncogene in primary NB tumors, suggesting that MRP1 may be a target for MYCN-mediated gene regulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_provenance.
- NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion evidence source_evidence_literature NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_provenance.
- NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion SIO_000772 14737110 NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_provenance.
- NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion wasDerivedFrom befree-20150227 NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_provenance.
- NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_assertion wasGeneratedBy ECO_0000203 NP551616.RApfYma48f-yf6rxv76kDUA5LU-re63s_PUGakMdKkx0A130_provenance.